11.0201.38% ( +0.150 )
Delay Closed: Nov 16, 16:08:11Financials
Q3 FY2026 Earnings
Financial report interval: 2026.06.30 - 2026.09.30
Overview: SH PHARMA(02607) the Revenue is 88.33 B (+9.97%), Miss estimate;the EBIT is 2.261 B (+37.62%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
88.33B9.97%
90.01B12.07%
-1.68B2.10%
EBITMiss expectations
2.26B37.62%
2.47B50.10%
-0.21B12.48%
EPS
TBA--
0.29843.53%
----
Upcoming earnings report - FY2026 Annual Earning Release
Available dateMar 26, 2027
Estimate Revenue347.4 B
Estimate EBIT--
Estimate EPS1.7388
Revenue
ActualEstimateUnit: HKD
Quarterly
EBIT
ActualEstimateUnit: HKD
Quarterly
Net income
ActualEstimateUnit: HKD
Quarterly
EPS
ActualEstimateUnit: HKD
Quarterly
